AMGN vs BCO · P/E 24, rev $36.75B vs P/E 25, rev $5.01B
Amgen Inc (AMGN) versus Brinks Company (BCO) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Brinks Company (BCO) is a security & protection services company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Not investment advice. Open the AMGN and BCO stock pages for the full models.
Not investment advice.